Clinical Trial

A Study of XW003 in Obese Participants With Obstructive Sleep Apnea Receiving Positive Airway Pressure Therapy

Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
The aim of the study is to assess the efficacy and safety of XW003 injections in obese participants with OSA receiving PAP
Protocol Amendment History 1 change
critical Recruitment opened 2026-04-14
Trial Details
NCT Number NCT07434050
Lead Sponsor Hangzhou Sciwind Biosciences Co., Ltd.
Conditions OSA - Obstructive Sleep Apnea, Obesity
Enrollment 140 participants
Start Date 2026-03-02
Primary Completion 2028-06-19 (estimated)
Study Completion 2028-06-19 (estimated)
Updated on ClinicalTrials.gov 2026-04-13